CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Inotiv Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Inotiv Inc
2701 Kent Ave
Phone: (317) 463-4527p:317 463-4527 WEST LAFAYETTE, IN  47906-1350  United States Ticker: NOTVNOTV
Business Summary
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20249/30/2023YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research
3826 Laboratory analytical instruments
2834 Pharmaceutical preparations
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Gregory C.Davis 70 1/1/2020 6/14/2017
President, Chief Executive Officer, Director Robert W.Leasure 64 1/12/2019 1/12/2019
Chief Financial Officer, Senior Vice President - Finance Beth A.Taylor 58 1/1/2023 3/9/2020
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
HistoTox Labs, Inc. 2108 55Th St Boulder CO United States
Bolder Biopath Inc 5541 Central Ave Boulder CO United States
Pre-Clinical Research Services, Inc. 1512 Webster Court Fort Collins CO United States
12 additional Subsidiary records available in full report.

Business Names
Business Name
BAS Evansville, Inc.
BASI
BASi Gaithersburg, Inc.
37 additional Business Names available in full report.

General Information
Number of Employees: 1,955 (As of 9/30/2023)
Outstanding Shares: 26,008,036 (As of 9/13/2024)
Shareholders: 429
Stock Exchange: NASD
Federal Tax Id: 351345024
Fax Number: (765) 497-1102
Email Address: bas@bioanalytical.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024